Literature DB >> 23725042

Biological parameters determining the clinical outcome of autologous cultures of limbal stem cells.

Graziella Pellegrini1, Paolo Rama, Stanislav Matuska, Alessandro Lambiase, Stefano Bonini, Augusto Pocobelli, Rossella Gisoldi Colabelli, Leopoldo Spadea, Romina Fasciani, Emilio Balestrazzi, Paolo Vinciguerra, Pietro Rosetta, Achille Tortori, Marco Nardi, Giovanna Gabbriellini, Carlo E Traverso, Claudio Macaluso, Lorena Losi, Antonio Percesepe, Beatrice Venturi, Francesca Corradini, Athanasios Panaras, Antonio Di Rocco, Paolo Guatelli, Michele De Luca.   

Abstract

AIM: Limbal cultures restore the corneal epithelium in patients with ocular burns. We investigated the biological parameters instrumental for their clinical success.
METHODS: We report a long-term multicenter prospective study on 152 patients carrying corneal destruction due to severe ocular burns, treated with autologous limbal cells cultured on fibrin and clinical-grade 3T3-J2 feeder cells. Clinical results were statistically evaluated both by parametric and nonparametric methods.
RESULTS: Clinical outcomes were scored as full success, partial success and failure in 66.05, 19.14 and 14.81% of eyes, respectively. The total number of clonogenic cells, colony size, growth rate and presence of conjunctival cells could not predict clinical results. Instead, the clinical data provided conclusive evidence that graft quality and likelihood of a successful outcome rely on an accurate evaluation of the number of stem cells detected before transplantation as holoclones expressing high levels of the p63 transcription factor. No adverse effects related to the feeder layer have been observed and the regenerated epithelium was completely devoid of any 3T3-J2 contamination.
CONCLUSION: Cultures of limbal stem cells can be safely used to successfully treat massive destruction of the human cornea. We emphasize the importance of a discipline for defining the suitability and the quality of cultured epithelial grafts, which are relevant to the future clinical use of any cultured cell type.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23725042     DOI: 10.2217/rme.13.43

Source DB:  PubMed          Journal:  Regen Med        ISSN: 1746-0751            Impact factor:   3.806


  49 in total

Review 1.  Outcomes of Limbal Stem Cell Transplant: A Meta-analysis.

Authors:  Qihua Le; Tulika Chauhan; Madeline Yung; Chi-Hong Tseng; Sophie X Deng
Journal:  JAMA Ophthalmol       Date:  2020-06-01       Impact factor: 7.389

2.  Next-generation stem cell therapy poised to enter EU market.

Authors:  Elie Dolgin
Journal:  Nat Biotechnol       Date:  2015-03       Impact factor: 54.908

Review 3.  [The emerging technology of tissue engineering : Focus on stem cell niche].

Authors:  U Schlötzer-Schrehardt; U Freudenberg; F E Kruse
Journal:  Ophthalmologe       Date:  2017-04       Impact factor: 1.059

4.  Cellular Stiffness as a Novel Stemness Marker in the Corneal Limbus.

Authors:  Tom Bongiorno; Jena L Chojnowski; James D Lauderdale; Todd Sulchek
Journal:  Biophys J       Date:  2016-10-18       Impact factor: 4.033

Review 5.  The application of human amniotic membrane in the surgical management of limbal stem cell deficiency.

Authors:  Qihua Le; Sophie X Deng
Journal:  Ocul Surf       Date:  2019-01-08       Impact factor: 5.033

6.  Diagnostic criteria for limbal stem cell deficiency before surgical intervention-A systematic literature review and analysis.

Authors:  Qihua Le; Tulika Chauhan; Sophie X Deng
Journal:  Surv Ophthalmol       Date:  2019-07-02       Impact factor: 6.048

7.  Corneal graft dellen in a patient implanted with a Boston keratoprosthesis type 1.

Authors:  Riccardo Scotto; Aldo Vagge; Carlo E Traverso
Journal:  Int Ophthalmol       Date:  2016-04-11       Impact factor: 2.031

8.  Chemically defined and xenogeneic-free culture method for human epidermal keratinocytes on laminin-based matrices.

Authors:  Monica Suryana Tjin; Alvin Wen Choong Chua; Karl Tryggvason
Journal:  Nat Protoc       Date:  2020-01-15       Impact factor: 13.491

Review 9.  Toward Combined Cell and Gene Therapy for Genodermatoses.

Authors:  Laura De Rosa; Maria Carmela Latella; Alessia Secone Seconetti; Cecilia Cattelani; Johann W Bauer; Sergio Bondanza; Michele De Luca
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-05-01       Impact factor: 10.005

10.  Regeneration of the entire human epidermis using transgenic stem cells.

Authors:  Tobias Hirsch; Tobias Rothoeft; Norbert Teig; Johann W Bauer; Graziella Pellegrini; Laura De Rosa; Davide Scaglione; Julia Reichelt; Alfred Klausegger; Daniela Kneisz; Oriana Romano; Alessia Secone Seconetti; Roberta Contin; Elena Enzo; Irena Jurman; Sonia Carulli; Frank Jacobsen; Thomas Luecke; Marcus Lehnhardt; Meike Fischer; Maximilian Kueckelhaus; Daniela Quaglino; Michele Morgante; Silvio Bicciato; Sergio Bondanza; Michele De Luca
Journal:  Nature       Date:  2017-11-08       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.